Given its association with age-related cognitive status and stroke recovery, changes in cGP/IGF-1 molar ratio and/or cGP concentration could be a better plasma biomarker to identify those at greater risk of cognitive decline and poor ability to recover from stroke. The gene discussed is IGF1; the disease is stroke disorder.